| Literature DB >> 25870317 |
Maxine Hardinge1, Joe Annandale2, Simon Bourne3, Brendan Cooper4, Angela Evans5, Daryl Freeman6, Angela Green7, Sabrine Hippolyte8, Vikki Knowles9, William MacNee10, Lynn McDonnell11, Kathy Pye12, Jay Suntharalingam13, Vandana Vora14, Tom Wilkinson15.
Abstract
The British Thoracic Society (BTS) Home Oxygen Guideline provides detailed evidence-based guidance for the use of home oxygen for patients out of hospital. Although the majority of evidence comes from the use of oxygen in patients with chronic obstructive pulmonary disease, the scope of the guidance includes patients with a variety of long-term respiratory illnesses and other groups in whom oxygen is currently ordered, such as those with cardiac failure, cancer and end-stage cardiorespiratory disease, terminal illness or cluster headache. It explores the evidence base for the use of different modalities of oxygen therapy and patient-related outcomes such as mortality, symptoms and quality of life. The guideline also makes recommendations for assessment and follow-up protocols, and risk assessments, particularly in the clinically challenging area of home oxygen users who smoke. The guideline development group is aware of the potential for confusion sometimes caused by the current nomenclature for different types of home oxygen, and rather than renaming them, has adopted the approach of clarifying those definitions, and in particular emphasising what is meant by long-term oxygen therapy and palliative oxygen therapy. The home oxygen guideline provides expert consensus opinion in areas where clinical evidence is lacking, and seeks to deliver improved prescribing practice, leading to improved compliance and improved patient outcomes, with consequent increased value to the health service. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.Entities:
Keywords: Long Term Oxygen Therapy (LTOT)
Mesh:
Substances:
Year: 2015 PMID: 25870317 DOI: 10.1136/thoraxjnl-2015-206865
Source DB: PubMed Journal: Thorax ISSN: 0040-6376 Impact factor: 9.139